Literature DB >> 11267390

Sirolimus (rapamycin)-based rescue treatment following chronic rejection after liver transplantation.

S Nishida1, A Pinna, R Verzaro, D Levi, T Kato, F Khan, J Nery, D Weppler, A Tzakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267390     DOI： 10.1016/s0041-1345(00)02566-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rinkesh K Bansal; Neeraj Saraf; Dheeraj Gautam; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-11-07

Review 2.  Single-agent immunosuppression after liver transplantation: what is possible?

Authors:  Maria L Raimondo; Andrew K Burroughs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Therapy for acute rejection in pediatric organ transplant recipients.

Authors:  Dominique Debray; Válerie Furlan; Véronique Baudouin; Lucile Houyel; Florence Lacaille; Christophe Chardot
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.